Active — Not RecruitingNot Applicable

Videoconferencing Adapted Physical Activity in Anorexia Nervosa: a Pilot Study

France30 participantsStarted 2022-12-01

Plain-language summary

The primary objectives of the APAREXIM'Pilot study are to evaluate the short- and medium-term effects of a live supervised Adapted Physical Activity (APA) program via videoconferencing on: * Feasibility and acceptability of APA via videoconferencing by the patients. * The primary symptoms of Anorexia Nervosa (AN). The secondary objectives are to evaluate the impact of this program on : * Mental health * Physical condition * Sleep-wake cycle (sleep disturbance and physical hyperactivity) The patients will first undergo an inclusion visit (T0) at the University Hospital of Caen, then a first evaluation session (T1) at the COMETE laboratory in Caen (physical tests, questionnaires, sleep diary, actimetry). They will then be randomly divided into 2 groups: 15 patients who will follow an APA program supervised by videoconference for 8 weeks (AM-APA) at their home, in addition to the usual outpatient treatment, and 15 patients who will benefit only from the classic outpatient treatment (AM-T). All patients will undergo two additional evaluation sessions at one week post-program (T2) and at 3 months post-program (T3).

Who can participate

Age range

13 Years – 18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patient between 13 and 18 years old, with typical anorexia nervosa symptoms diagnosed by a specialist. * Patient followed in outpatient care. * Collection of the signature of the informed consent. * Patient affiliated to the health insurance system. * Agreement of the legal representatives Exclusion Criteria: * Patient with contraindications to physical activity or with a state of health judged critical by the doctor. * Person deprived of liberty by judicial or administrative decision, or under guardianship or curatorship. * Pregnant or breast-feeding woman. * Patient included in another biomedical research protocol during the present study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Treatment Acceptability and Preferences questionnaire (TAP-Q)

Timeframe: T2 (just after the APA program)

Eating Attitude Test - 26 (EAT-26)

Timeframe: Change from T1 (just before the APA program) at T2 (just after the APA program) then T3 (8 weeks after the APA program)

Trial details

NCT IDNCT05770089

SponsorUniversity Hospital, Caen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

View on ClinicalTrials.gov More Anorexia Nervosa trials